Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
about
Repeat dosing of rocuronium-sugammadex: unpredictable.Effect of Sugammadex on Postoperative Bleeding and Coagulation Parameters After Septoplasty: A Randomized Prospective Study.Sugammadex for reversal of neuromuscular blockade: a retrospective analysis of clinical outcomes and cost-effectiveness in a single center.Comparison of Sugammadex versus Neostigmine Costs and Respiratory Complications in Patients with Obstructive Sleep ApnoeaPostoperative Respiratory Failure in a Patient with Undiagnosed Myastenia Gravis.Anesthetic consideration for neurointerventional proceduresSugammadex for reversal of rocuronium-induced neuromuscular blockade in pediatric patients: A systematic review and meta-analysis.Staggering the dose of sugammadex lowers risks for severe emergence cough: a randomized control trialPreparing for the unexpected: special considerations and complications after sugammadex administrationFeasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases.Neostigmine induced coronary artery spasm: A case report and literature review.Profile of sugammadex for reversal of neuromuscular blockade in the elderly: current perspectives.Effect of Low and High Dose Sugammadex on the Coagulation and Fibrinolytic System in Rats
P2860
Q34000939-2C2721B0-AA3E-4768-A13E-C35E8C9E1460Q35965686-CFEEBFDC-7EED-40A1-8932-2B361DA3796BQ36603957-EEBCEDEC-DF90-413D-BC98-1583818D8FFBQ36972071-11449030-88E9-487E-A25B-858617ADC8EBQ36972089-239607EA-FBE4-4B8F-91FC-66E7306F4DFEQ38271606-61FA897F-4AE2-4324-9D10-9A71FA4096EEQ38936914-C8861903-3BEE-4B2B-9EF4-9AFF8C3148A9Q42375178-0438D137-1584-40AD-A468-CB90D43A7D11Q42682587-FE4B5CE6-6126-495F-9ACD-DA1D8CC2840EQ43213284-E967BB70-DA67-4137-BB6D-2471EB470750Q47099109-2A9B3786-3390-464C-BDA0-CBB7775654DDQ47213588-DFDB4682-FC43-4E25-9F80-C9173AEEEB30Q59104207-F92C0B0D-6CB2-4847-A301-0F47DC089D1B
P2860
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 25 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
@en
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.
@nl
type
label
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
@en
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.
@nl
prefLabel
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
@en
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review.
@nl
P2860
P356
P1433
P1476
Sugammadex as a reversal agent for neuromuscular block: an evidence-based review
@en
P2093
Heidrun Fink
P2860
P356
10.2147/CE.S35675
P407
P577
2013-09-25T00:00:00Z